🔎 Trials Near Me

Početna › Prekomjerna tjelesna masa › Texas › Dallas

Kliničke studije za Prekomjerna tjelesna masa u gradu Dallas, TX

20 studija za Prekomjerna tjelesna masa traži sudionike na lokacijama u gradu Dallas i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

U tijeku regrutacijaFaza 2
  • Velocity Clinical Research - Dallas /ID# 282734, Dallas
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

U tijeku regrutacijaFaza 3
  • UT Southwestern Med Center, Dallas
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07533175

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

U tijeku regrutacijaFaza 3
  • North Texas Endocrine Center, Dallas
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

U tijeku regrutacijaFaza 3
  • UT Southwestern Med Center, Dallas
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

U tijeku regrutacijaFaza 3
  • Cedar Health Research - Texas Native Health, Dallas
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07794579

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • Velocity Clinical Research, Dallas, Dallas
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

U tijeku regrutacijaFaza 3
  • UT Southwestern Medical Center, Dallas
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07392190

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

U tijeku regrutacijaFaza 3
  • Thyroid Endocrinology and Diabetes, Dallas
  • Soltero Cardiovascular Research Center, Dallas
  • Zenos Clinical Research, Dallas
  • i još 2
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • Velocity Clinical Research, Dallas, Dallas
  • UT Southwestern Medical Center, Dallas
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

U tijeku regrutacijaFaza 2
  • FutureSearch Trials of Dallas, Dallas
Od 18 do 75 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07589608

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • Velocity Clinical Research, Dallas
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • University of Texas Southwestern Medical Center - Children's Medical Center Dallas, Dallas
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07351045

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

U tijeku regrutacijaFaza 3
  • Cedar Health Research, Dallas
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

U tijeku regrutacijaFaza 2
  • Velocity Clinical Research, Dallas, Dallas
  • FutureSearch Trials of Dallas, Dallas
Od 18 do 75 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

U tijeku regrutacijaFaza 2
  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
Od 18 do 75 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

U tijeku regrutacijaFaza 3
  • Cedar Health Research, LLC, Dallas
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684235

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

U tijeku regrutacijaFaza 3
  • Mercy Family Clinic, Dallas
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT07509307

Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program

U tijeku regrutacija
  • University of Texas Southwestern, Children's Health, Dallas
Od 6 do 14 godina · Oba spola · Ažurirano 30. ožu 2026. · NCT07342855

Healthy Living BEYOND Weight Study

U tijeku regrutacijaOpažajna studija
  • American Heart Association, Dallas
Od 18 godina i više · Oba spola · Ažurirano 6. kol 2025. · NCT07075341

Studije za Prekomjerna tjelesna masa u drugim gradovima

Ostale studije u gradu Dallas

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.